Low vitamin D levels affect drug efficacy in HCV patients

12/20/2009 | Medscape (free registration)

An Italian study showed hepatitis C patients have lower serum levels of 25-hydroxyvitamin D than people without the virus, which affects treatment efficacy. The study showed that as vitamin D levels decline, so do the chances that a patient with chronic HCV will have a sustained response to interferon and ribavirin.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC